Illumina Appoints Daniel Bradbury to Board of Directors.
Illumina Inc. announced that Daniel M. Bradbury has joined the company's Board of Directors. Mr. Bradbury is currently Chief Operating Officer of Amylin Pharmaceuticals in San Diego and a member of the Board of Directors of Peninsula Pharmaceuticals. Prior to joining Amylin in 1994 Dan spent eleven years in various international sales and marketing roles with Beecham Pharmaceuticals and SmithKline Beecham Pharmaceuticals.
